{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T14:58:37Z","timestamp":1778079517614,"version":"3.51.4"},"reference-count":40,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Tennessee System","award":["E073610699"],"award-info":[{"award-number":["E073610699"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Community pharmacists have become increasingly exposed to opioid use disorders in recent decades. However, both pharmacist training and traditional practice environments have not been adequate to prepare the pharmacist for both the patient care needs and regulatory barriers of patients experiencing opioid use disorders (OUD). As a result, there is a need to increase pharmacists\u2019 awareness of both the overall patient experience as they navigate their OUD and the role of the community pharmacy as a touchpoint within that experience. To this end, a Community-Centered Patient Journey in Drug Addiction Treatment journey map was developed with expert insights, clinical experience, and in-depth interviews (conducted in spring of 2021) with 16 participants enrolled in licensed opioid treatment programs in Tennessee. Patients, policymakers, clinicians, and academic researchers were involved in the map development. Lived experiences of key informants were captured via in-depth interviews. A consensus decision-making approach was used throughout the patient journey map development process. The final patient journey map illustrates a non-linear pathway, describes the central role of the patient\u2019s community, and emphasizes three major \u201cpain points\u201d within the system (access, adherence, and affordability). Future research should investigate the impact of such a journey map on pharmacy personnel\u2019s knowledge, attitudes, and behaviors.<\/jats:p>","DOI":"10.3390\/pharmacy11020052","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T06:14:58Z","timestamp":1678774498000},"page":"52","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Community-Centered Patient Journey Map in Opioid Use Disorder: A Tool to Address Compassion Fatigue among Community Pharmacists"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-4643","authenticated-orcid":false,"given":"Kenneth Charles","family":"Hohmeier","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Nashville, TN 37211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Cernasev","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Nashville, TN 37211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Leibold","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Translational Science, College of Pharmacy, University of Tennessee Health Science Center, Nashville, TN 37211, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd M.","family":"Moore","sequence":"additional","affiliation":[{"name":"Department of Psychology, University of Tennessee, Knoxville, TN 37996, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Schlesinger","sequence":"additional","affiliation":[{"name":"Tennessee Department of Mental Health & Substance Abuse Services, Nashville, TN 37243, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Cochran","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, University of Utah, Salt Lake City, UT 84112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana","family":"Arce","sequence":"additional","affiliation":[{"name":"Tennessee Department of Mental Health & Substance Abuse Services, Nashville, TN 37243, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Geminn","sequence":"additional","affiliation":[{"name":"Tennessee Department of Mental Health & Substance Abuse Services, Nashville, TN 37243, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Chisholm-Burns","sequence":"additional","affiliation":[{"name":"Office of the Provost, Oregon Health & Science University, Portland, OR 97239, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"ref_1","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadonemaintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdoseepidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide USpopulation receiving opioid use disorder services","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"key":"ref_4","unstructured":"The Centers for Disease Control and Prevention (2022, October 07). National Center for Health Statistics, Available online: https:\/\/www.cdc.gov\/nchs\/."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain Physician"},{"key":"ref_6","unstructured":"The Centers for Disease Control Prevention, U.S. (2022, October 07). Opioid Dispensing Rate Maps, Available online: https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ADM.0000000000000148","article-title":"Screening community pharmacy patients for risk of prescription opioid misuse","volume":"9","author":"Cochran","year":"2015","journal-title":"J. Addict. Med."},{"key":"ref_8","unstructured":"SAMHSA (2022). Results from the 2020 National Survey on Drug Use and Health: Mental Health Detailed Tables, Substance Abuse and Mental Health Services Administration."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: The TROUP Study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"key":"ref_10","unstructured":"Muhuri, P.K., Gfroerer, J.C., and Davies, M.C. (2016, May 13). Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States, Available online: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/DR006\/DR006\/nonmedical-pain-reliever-use-2013.htm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The Changing Face of Heroin Use in the United States: A Retrospective Analysis of the Past 50 Years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.drugalcdep.2015.12.026","article-title":"Predictors of transition to heroin use among non-opioid dependent illicit pharmaceutical opioid users: A natural history study","volume":"160","author":"Carlson","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"ref_13","unstructured":"National Institute on Drug Abuse (2023, February 16). Heroin DrugFacts, Available online: http:\/\/www.drugabuse.gov\/publications\/drugfacts\/heroin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.sapharm.2013.07.004","article-title":"Theoretical exploration of Tennessee community pharmacists\u2019 perceptions regarding opioid pain reliever abuse communication","volume":"10","author":"Hagemeier","year":"2014","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/CEH.0000000000000233","article-title":"Changes in pharmacists\u2019 perceptions after a training in opioid misuse and accidental overdose prevention","volume":"39","author":"Eukel","year":"2019","journal-title":"J. Contin. Educ. Health Prof."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.japh.2022.07.003","article-title":"Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107968","DOI":"10.1016\/j.drugalcdep.2020.107968","article-title":"Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study","volume":"211","author":"Joudrey","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addict. Sci. Clin. Pract."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/add.15353","article-title":"Pharm-OUD-Care Collaborative Investigators. Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: Results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network","volume":"116","author":"Wu","year":"2021","journal-title":"Addiction"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/IPRP.S99539","article-title":"Prescription opioid abuse: Pharmacists\u2019 perspective and response","volume":"5","author":"Cochran","year":"2016","journal-title":"Integr. Pharm. Res. Pract."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cernasev, A., Desselle, S., Hohmeier, K.C., Canedo, J., Tran, B., and Wheeler, J. (2021). Pharmacy technicians, stigma, and compassion fatigue: Front-line perspectives of pharmacy and the US opioid epidemic. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18126231"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/08897077.2021.1900988","article-title":"Pharmacists\u2019 stigma toward patients engaged in opioid misuse: When \u201csocial distance\u201d does not mean disease prevention","volume":"42","author":"Werremeyer","year":"2021","journal-title":"Subst. Abus."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jen.2022.07.006","article-title":"Expressions of Compassion Fatigue by Emergency Department Nurses Caring for Patients With Opioid and Substance Use Disorders","volume":"48","author":"Dowdell","year":"2022","journal-title":"J. Emerg. Nurs."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13011-021-00374-x","article-title":"Qualitative assessment of patients\u2019 perspectives and needs from community pharmacists in substance use disorder management","volume":"16","author":"Fatani","year":"2021","journal-title":"Subst. Abus. Treat. Prev. Policy"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/10410236.2019.1598614","article-title":"Reducing Health-Related Stigma Through Narrative Messages","volume":"35","author":"Heley","year":"2020","journal-title":"Health Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/12460125.2016.1187394","article-title":"An integrated patient journey mapping tool for embedding quality in healthcare service reform","volume":"25","author":"McCarthy","year":"2016","journal-title":"J. Decis. Syst."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1016\/j.sapharm.2021.06.015","article-title":"Research methods from human-centered design: Potential applications in pharmacy and health services research","volume":"17","author":"Flood","year":"2021","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1007\/s12325-020-01519-3","article-title":"A narrative review of the patient journey through the lens of non-communicable diseases in low-and middle-income countries","volume":"37","author":"Devi","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"c4078","DOI":"10.1136\/bmj.c4078","article-title":"Process mapping the patient journey: An introduction","volume":"341","author":"Trebble","year":"2010","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1609406917733847","DOI":"10.1177\/1609406917733847","article-title":"Thematic analysis: Striving to meet the trustworthiness criteria","volume":"16","author":"Nowell","year":"2017","journal-title":"Int. J. Qual. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Montiel Ishino, F.A., McNab, P.R., Gilreath, T., Salmeron, B., and Williams, F. (2020). A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017\u20132018 United States national survey. BMC Public Health, 20.","DOI":"10.1186\/s12889-020-09856-2"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/ajhp\/zxy089","article-title":"The opioid crisis: Origins, trends, policies, and the roles of pharmacists","volume":"76","author":"Spivey","year":"2019","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"108257","DOI":"10.1016\/j.drugalcdep.2020.108257","article-title":"Knowledge, preparedness, and compassion fatigue among law enforcement officers who respond to opioid overdose","volume":"217","author":"Carroll","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"102796","DOI":"10.1016\/j.drugpo.2020.102796","article-title":"The bell tolls for thee & thine: Compassion fatigue & the overdose epidemic","volume":"85","author":"Winstanley","year":"2020","journal-title":"Int. J. Drug Policy"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/nhs.12387","article-title":"Toward a comprehensive, theoretical model of compassion fatigue: A n integrative literature review","volume":"20","author":"Coetzee","year":"2018","journal-title":"Nurs. Health Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/08897077.2021.1975872","article-title":"Health professionals\u2019 attitudes toward medications for opioid use disorder","volume":"43","author":"Brown","year":"2022","journal-title":"Subst. Abus."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11420-018-9643-3","article-title":"Improvement in residents\u2019 attitudes toward individuals with substance use disorders following an online training module on stigma","volume":"15","author":"Avery","year":"2019","journal-title":"HSS J. \u00ae"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/08897077.2020.1843104","article-title":"Incoming medical students\u2019 knowledge of and attitudes toward people with substance use disorders: Implications for curricular training","volume":"42","author":"Moses","year":"2021","journal-title":"Subst. Abus."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/08897077.2019.1616349","article-title":"Pharmacists\u2019 attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature","volume":"40","author":"Muzyk","year":"2019","journal-title":"Subst. Abus."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1331\/1544345052843200","article-title":"Pharmacists\u2019 and pharmacy technicians\u2019 perceptions and attitudes toward dispensing buprenorphine and buprenorphine\/naloxone to patients with opioid dependence","volume":"45","author":"Raisch","year":"2005","journal-title":"J. Am. Pharm. Assoc."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/11\/2\/52\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:54:41Z","timestamp":1760122481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/11\/2\/52"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["pharmacy11020052"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy11020052","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]}}}